Episode 20 – Dr. Russell Ross: The Dynamic Nature of Atherosclerotic Plaque

  1. Home
  2. »
  3. History of cardiology
  4. »
  5. Episode 20 – Dr. Russell Ross: The Dynamic Nature of Atherosclerotic Plaque

As an introduction to this article, it is important to remember that by the middle of the 20th century, it was already known that atherosclerotic plaque was responsible for the obstruction of coronary arteries and that its rupture could trigger a heart attack.

At that time, two major therapeutic approaches emerged.
The first involved compressing the plaque to reopen the artery, while the second aimed to bypass the obstruction through coronary artery bypass surgery.

Over time, however, it became clear that these treatments did not cure the disease itself. They mainly relieved symptoms related to the obstructions, while the atherosclerotic disease remained present. The risk of acute cardiovascular events therefore persisted despite these interventions.

At the time, no one could truly answer the fundamental question: why do these plaques form?

Atherosclerosis remained a poorly understood phenomenon.

Two major hypotheses opposed one another:

  • one attributed its development to a progressive accumulation of cholesterol within the arterial wall
  • the other pointed instead toward an inflammatory process

A researcher fascinated by tissue repair

It was in this context that the work of Russell Ross would profoundly transform the understanding of atherosclerosis.

Born on May 25, 1929, in St. Augustine, Florida, he obtained a degree in dental medicine from the Columbia University College of Dental Medicine in New York in 1955. He later pursued studies in experimental pathology at the University of Washington in Seattle, where he earned his doctorate after several years of research.

He subsequently joined the Department of Pathology at the University of Washington, eventually becoming chairman of the department.

Dr. Ross became particularly interested in the mechanisms involved in wound healing.

His research led him to ask a fundamental question: could a process normally useful for healing, under certain circumstances, become the cause of disease?

In other words, could a mechanism designed to repair tissues also become harmful when activated inappropriately?

A discovery that transformed cardiology

His work led to a major discovery.
The same cells involved in tissue healing were also found surrounding atherosclerotic plaques.

From this observation, Dr. Ross developed a revolutionary hypothesis: atherosclerosis was actually an inflammatory response of the arterial wall to cholesterol accumulation.

This discovery finally reconciled the two previously opposing theories.

Supporters of the lipid theory were partly correct, just as those emphasizing the central role of inflammation were also partly correct.

Cholesterol accumulation became recognized as the trigger for the inflammatory reaction, and this entire process gradually led to the formation and progression of atherosclerotic plaque.

A dynamic and unstable disease

This new understanding would transform modern cardiology.

Atherosclerosis was no longer viewed as a simple passive cholesterol deposit, but rather as a dynamic, active, and evolving disease.

It became understood that a plaque could remain stable for years before suddenly becoming unstable and rupturing.

When rupture occurs, the plaque contents come into contact with circulating blood, immediately activating the coagulation process.

A clot — called a thrombus — can then rapidly form and partially or completely block the coronary artery.

This mechanism is responsible for the majority of myocardial infarctions.

The true enemy had finally been identified.

A lasting legacy

The work of Dr. Russell Ross profoundly influenced the modern understanding of cardiovascular disease.

It also paved the way for the development of new therapeutic strategies aimed not only at treating obstructions, but also at stabilizing atherosclerotic plaques and reducing vascular inflammation.

Dr. Russell Ross died on March 18, 1999, in Seattle, Washington.